TY  - JOUR
AU  - Alfonso, Fernando
AU  - Perez-Vizcayno, Maria Jose
AU  - del Blanco, Bruno Garcia
AU  - Garcia-Touchard, Arturo
AU  - Lopez-Minguez, Jose-Ramon
AU  - Masotti, Monica
AU  - Zueco, Javier
AU  - Melgares, Rafael
AU  - Mainar, Vicente
AU  - Moreno, Raul
AU  - Dominguez, Antonio
AU  - Sanchis, Juan
AU  - Bethencourt, Armando
AU  - Moreu, Jose
AU  - Cequier, Angel
AU  - Marti, Vicens
AU  - Otaegui, Imanol
AU  - Bastante, Teresa
AU  - Gonzalo, Nieves
AU  - Jimenez-Quevedo, Pilar
AU  - Cardenas, Alberto
AU  - Fernandez, Cristina
AU  - Spanish Soc Cardiology
PY  - 2016
DO  - 10.1161/CIRCINTERVENTIONS.115.003479
SN  - 1941-7640
UR  - http://hdl.handle.net/10668/19086
T2  - Circulation-cardiovascular interventions
AB  - Background-Treatment of patients with drug-eluting stent (DES) in-stent restenosis (ISR) is more challenging than that of patients with bare-metal stent ISR. However, the results of everolimus-eluting stents (EES) in these distinct scenarios remain...
LA  - en
PB  - Lippincott williams & wilkins
KW  - angiography
KW  - drug-eluting stents
KW  - everolimus
KW  - metal
KW  - regression analysis
KW  - restenosis
KW  - Coated balloon angioplasty
KW  - Efficacy
KW  - Neoatherosclerosis
KW  - Implantation
KW  - Multicenter
KW  - Outcomes
KW  - Safety
TI  - Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials
TY  - research article
VL  - 9
ER  -